Rare lephants

Screener

enGene Therapeutics Inc.

ENGN ·Healthcare, Drug Manufacturers - General

Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation

EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding

Share-Based Metrics › Shares Outstanding

← 5Y 10Y MAX →

Shares Outstanding

Fiscal Year	Shares Outstanding
FY2022	36.0M
FY2023	38.1M
FY2024	37.8M
FY2025	51.1M
FY2026	67.0M

About Contact Terms Privacy